These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment of Filing Fee (Check the appropriate box):
|
||
|
☒
|
No fee required.
|
|
|
☐
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
Total fee paid:
|
|
|
☐
|
Fee paid previously with preliminary materials.
|
|
|
☐
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.
|
|
|
(1)
|
Amount Previously Paid:
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
Filing Party:
|
|
|
(4)
|
Date Filed:
|
|
|
|
Page
|
|
4
|
|
|
4
|
|
|
|
4 |
|
5
|
|
|
5
|
|
|
6
|
|
|
6
|
|
|
7
|
|
|
9
|
|
|
11
|
|
|
11
|
|
|
14
|
|
|
14
|
|
|
|
15 |
|
16
|
|
|
18
|
|
|
18
|
|
| Compensation Discussion and Analysis | 18 |
|
26
|
|
|
29
|
|
|
|
30 |
|
32
|
|
|
35
|
|
|
36
|
|
|
37
|
|
|
38
|
|
|
38
|
|
|
38
|
|
|
38
|
|
|
39
|
|
|
39
|
|
Name
|
Class
|
Age
|
Position
|
Elected Director (Calendar Year)
|
Current Term Expires
(Calendar Year)
|
Expiration of Term for which Nominated
(Calendar Year)
|
||||||
|
Director Nominees
|
||||||||||||
|
Marcel Gani
(1)(2)
|
II
|
64
|
Director
|
2015
|
2017
|
2020
|
||||||
|
Tal Payne
(2)
|
II
|
45
|
Director
|
2015
|
2017
|
2020
|
||||||
|
Continuing Directors
|
||||||||||||
|
Dan Avida
(1)(3)
|
I
|
53
|
Director
|
2007
|
2019
|
|||||||
|
Yoni Cheifetz
(3)
|
I
|
56
|
Director
|
2010
|
2019
|
|||||||
|
Doron Inbar
(1)(2)
|
III
|
67
|
Director
|
2015
|
2019
|
|||||||
|
Guy Sella
|
III
|
52
|
Chief Executive Officer and Chairman of the Board
|
2006
|
2018
|
|||||||
|
Avery More
(1)(3)
|
III
|
62
|
Director
|
2006
|
2018
|
|||||||
| (1) |
Member of the Compensation Committee.
|
| (2) |
Member of the Audit Committee.
|
| (3) |
Member of the Nominating and Corporate Governance Committee.
|
|
The Board of Directors recommends a vote FOR the election of each of the two director nominees.
|
| · |
appointing, compensating, retaining, evaluating, terminating and overseeing our outside auditor;
|
| · |
at least annually, reviewing the independence of our outside auditor;
|
| · |
reviewing with our independent registered public accounting firm the matters required to be reviewed by applicable auditing requirements;
|
| · |
approving in advance all audit and permissible non-audit services to be performed by our independent registered public accounting firm;
|
| · |
meeting to review and discuss with management and the outside auditor the annual audited and quarterly financial statements of the Company and the independent auditor’s reports related to the financial statements;
|
| · |
receiving reports from management regarding, and reviewing and discussing the adequacy and effectiveness of, the Company’s disclosure controls and procedures;
|
| · |
establishing and overseeing procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal controls, auditing and federal securities law matters;
|
| · |
establishing and periodically reviewing policies and procedures for the review, approval and ratification of related person transactions; and
|
| · |
overseeing the preparation of the report of the audit committee that SEC rules require to be included in our annual proxy statement.
|
| · |
overseeing our overall compensation philosophy, policies and programs;
|
| · |
reviewing and approving corporate goals and objectives relevant to the compensation of our Chief Executive Officer, evaluating the Chief Executive Officer’s performance in light of those goals and objectives, approving grants of equity awards to the Chief Executive Officer and recommending to the independent directors the Chief Executive Officer’s compensation level based on this evaluation;
|
| · |
overseeing the evaluation of other executive officers and approving equity awards to these officers, and setting their compensation based upon the recommendation of the Chief Executive Officer;
|
| · |
reviewing and approving the design of other benefit plans pertaining to executive officers;
|
| · |
reviewing and approving employment agreements and other similar arrangements between us and our executive officers; and
|
| · |
overseeing preparation of the report of the compensation committee to the extent required by SEC rules to be included in our annual meeting proxy statement.
|
| · |
identifying individuals qualified to become members of our Board of Directors, consistent with criteria approved by our Board of Directors;
|
| · |
assessing the contributions and independence of incumbent directors in determining whether to recommend them for reelection to the Board;
|
| · |
developing and recommending to our Board of Directors a set of corporate governance guidelines and principles;
|
| · |
establishing procedures for the consideration of Board candidates recommended by the Company’s stockholders;
|
| · |
recommending to the Board candidates to be elected by the Board to fill vacancies and newly created directorships and candidates for election or reelection at each annual stockholders’ meeting;
|
| · |
periodically reviewing the Board’s leadership structure, size, composition and functioning;
|
| · |
overseeing succession planning for positions held by executive offices;
|
| · |
overseeing the evaluation of the Board and its committees; and
|
| · |
annually reviewing the compensation of directors for service on the Board and its committees and recommend changes in compensation to the Board as appropriate.
|
| · |
demonstrated business acumen and leadership, and high levels of accomplishment;
|
| · |
ability to exercise sound business judgment and to provide insight and practical wisdom based on experience;
|
| · |
commitment to understand the Company and its business, industry and strategic objectives;
|
| · |
integrity and adherence to high personal ethics and values, consistent with our Code of Business Conduct and Ethics;
|
| · |
commitment to enhancing stockholder value;
|
| · |
willingness to act in the interest of all stockholders; and
|
| · |
for non-employee directors, independence under Nasdaq listing standards and other applicable rules and regulations.
|
|
2015
|
2016
|
Six Months Ended
December 31,
2016
|
||||||||||
|
In thousands of Dollars
|
||||||||||||
|
Audit fees(1)
|
890
|
525
|
395
|
|||||||||
|
Audit Related fees(2)
|
22
|
-
|
-
|
|||||||||
|
Tax fees(3)
|
80
|
27
|
26
|
|||||||||
|
Total audit and related fees
|
992
|
552
|
421
|
|||||||||
| (1) |
“Audit fees” are fees for audit services for each of the years shown in this table, including fees associated with the annual audit (including audit of our internal control over financial reporting in fiscal year 2016 and for the six months ended December 31, 2016), reviews of our quarterly financial results submitted on Form 10-Q, consultations on various accounting issues
and services rendered for the filing of our Form S-1 and fees related to our initial public offering in fiscal year 2015.
|
|
(2)
|
Represents accounting consultations regarding financial accounting and reporting standards.
|
| (3) |
Represents professional services rendered for tax compliance, tax advice, tax planning and review our Israeli tax returns.
|
|
The Board of Directors recommends a vote FOR the ratification of the appointment of KOST FORER GABBAY & KASIERER, A MEMBER OF EY GLOBAL for 2017.
|
|
The Board of Directors recommends a vote for “EVERY YEAR” as the frequency with which stockholders are provided future advisory votes to approve executive compensation.
|
| · |
each person known to us to beneficially own 5% or more of the outstanding shares of our common stock;
|
| · |
each member of our Board of Directors and director nominees;
|
| · |
each of our named executive officers; and
|
| · |
the members of our Board of Directors and our executive officers as a group.
|
|
Shares Beneficially Owned
|
||||||||
|
Name of Beneficial Owner
|
Shares
|
%
|
||||||
|
5% Stockholders:
|
||||||||
|
Affiliates of Opus Capital Venture Partners V, L.P.(1)
|
2,500,000
|
6.0
|
%
|
|||||
|
Affiliates of Pacven Walden Ventures VI, L.P.(2)
|
2,225,280
|
5.4
|
%
|
|||||
|
FMR LLC (3
)
|
3,046,980
|
7.3
|
%
|
|||||
|
Senvest Management, LLC(4)
|
2,644,057
|
6.4
|
%
|
|||||
|
Odey Asset Management Group Ltd.(5)
|
3,301,780
|
8.0
|
%
|
|||||
|
Directors and Named Executive Officers:
|
||||||||
|
Guy Sella(6)
|
1,120,395
|
2.7
|
%
|
|||||
|
Ronen Faier(7)
|
249,339
|
*
|
||||||
|
Zvi Lando(8)
|
287,672
|
*
|
||||||
|
Yoav Galin(9)
|
566,005
|
1.4
|
%
|
|||||
|
Lior Handelsman(10)
|
431,000
|
1.0
|
%
|
|||||
|
Dan Avida(11)
|
2,524,138
|
6.1
|
%
|
|||||
|
Yoni Cheifetz(12)
|
34,127
|
*
|
||||||
|
Marcel Gani(13)
|
24,118
|
*
|
||||||
|
Doron Inbar(14)
|
236,341
|
*
|
||||||
|
Avery More(15)
|
694,438
|
1.7
|
%
|
|||||
|
Tal Payne (16)
|
13,008
|
*
|
||||||
|
All directors and executive officers as a group (13 individuals)(17)
|
6,794,772
|
16.4
|
%
|
|||||
| * |
Represents beneficial ownership of less than 1%.
|
| (1) |
Opus Capital Venture Partners V, L.P.’s investment committee consists of Carl Showalter, Dan Avida, Gill Cogan and Joseph Cutts. Each of these individuals has shared voting and investment power over the shares held by Opus Capital Venture Partners, L.P. The principal business address of each of the Opus Capital Venture Partners Funds is 2730 Sand Hill Road, Suite 150, Menlo Park, CA 94025.
|
| (2) |
All shares are held by Pacven Walden Ventures VI, L.P. and Pacven Walden Ventures Parallel VI, L.P. (together with Pacven Walden Ventures VI, L.P., the “Pacven Walden Funds”). The general partner of Pacven Walden Ventures VI, L.P. (“Pacven VI”) and Pacven Walden Ventures VI Parallel VI, L.P. (“Pacven VI Parallel”) is Pacven Walden Management VI Co. Ltd., which is affiliated with Walden International, a venture capital firm. Pacven Walden Funds' investment committee consists of Lip-Bu Tan and Andrew Kau who have shared voting and investment power over the shares held by Pavcen Walden Funds.
The business address of Pacven VI, Pacven VI Parallel and Walden International is 333 Bush Street, 28th Floor, San Francisco, California 94104
.
|
| (3) |
Based solely on a Schedule 13G/A filed with the SEC on February 14, 2017 by FMR LLC and Abigail P. Johnson, who is a director, the Chairman and the Chief Executive Officer of FMR LLC. Schedule 13G/A contains information as of December 31, 2016. According to Schedule 13G/A, FMR LLC has sole voting power over 461 shares and sole dispositive power over all of the shares reported above. The address of FMR LLC is 245 Summer Street, Boston, MA 02210. The shares are, or may be deemed, beneficially owned by FMR LLC and its subsidiaries and affiliates, including Fidelity Institutional Asset Management Trust Company.
|
|
(4)
|
Based solely on a Schedule 13G/A filed with the SEC by Senvest Management, LLC and Richard Mashaal, who is the managing member of Senvest Management, LLC, on February 13, 2017. Schedule 13G/A contains information as of December 31, 2016. Senvest Management, LLC and Richard Mashaal report having shared voting and shared dispositive power over all of the shares reported above. The address of the reporting persons is c/o Senvest Management, LLC is 540 Madison Avenue, 32nd Floor New York, New York 10022
|
| (5) |
Based solely on a Schedule 13G filed with the SEC by Odey Asset Management Group Ltd. (“OAM Ltd”), Odey Asset Management LLP (“OAM LLP”), Odey Holdings AG (“Odey Holdings”) and Robin Crispin William Odey on February 14, 2017. Schedule 13G contains information as of December 31, 2016. Shares reported in the Schedule 13G for OAM LLP represent shares held for the benefit of investment advisory clients of OAM LLP. OAM Ltd is the managing member of OAM LLP, Odey Holdings is the sole stockholder of OAM Ltd, and Mr. Odey is the sole stockholder of Odey Holdings. Each reporting person reported having shared voting and shared dispositive power over all of the shares reported above. The address of the reporting persons is c/o Odey Asset Management Group Ltd., 12 Upper Grosvenor Street, London, United Kingdom, W1K 2ND
|
| (6) |
Consists of 450,479 shares of common stock owned of record by Mr. Sella, and 669,916 shares of common stock issuable upon exercise of
options exercisable
within 60 days of March 1, 2017.
|
| (7) |
Consists of 6,583 shares of common stock owned of record by Mr. Faier and 242,756 shares of common stock issuable upon exercise of
options exercisable
within 60 days of March 1, 2017.
|
| (8) |
Consists of 6,583 shares of common stock owned of record by Mr. Lando and 281,089 shares of common stock issuable upon exercise of
options exercisable
within 60 days of March 1, 2017.
|
| (9) |
Consists of 439,916 shares of common stock owned of record by Mr. Galin and 126,089 shares of common stock issuable upon exercise of
options exercisable
within 60 days of March 1, 2017.
|
| (10) |
Consists of 233,839 shares of common stock owned of record by Mr. Handelsman and 197,161 shares of common stock issuable upon exercise of
options exercisable
within 60 days of March 1, 2017.
|
| (11) |
Consists of shares described in Note (1) above, 10,760 shares of common stock owned of record by
Mr. Avida
, 2,248 shares of common stock issuable upon settlement of
restricted stock units
which will vest and settle within 60 days of March 1, 2017 and 11,130 shares of common stock held by The Zarbu Revocable Trust, c/o Dan Avida.
|
| (12) |
Consists of 31,879 shares of common stock owned of record by Mr. Cheifetz and 2,248 shares of common stock issuable upon settlement of
restricted stock units
which will vest and settle within 60 days of March 1, 2017.
|
| (13) |
Consists of 10,760 shares of common stock owned of record by Mr. Gani, 2,248 shares of common stock issuable upon settlement of
restricted stock units
which will vest and settle within 60 days of March 1, 2017, 5,555 shares of common stock held directly by Marcel Gani 2002 Living Trust and 5,555 shares of common stock held directly by ALGA Partners LLC. Mr. Gani, in his capacity as trustee, has voting and investment power over the shares owned by the Marcel Gani 2002 Living Trust. Mr. Gani, in his capacity as manager, has voting and investment power over the shares owned by ALGA Partners LLC.
|
| (14) |
Consists of 10,760 shares of common stock owned of record by Mr. Inbar, 223,333 shares of common stock issuable upon exercise of
options exercisable
within 60 days of March 1, 2017, and 2,248 shares of common stock issuable upon settlement of restricted stock units which will vest and settle
within 60 days of March 1, 2017.
|
| (15) |
Consists of 168,588 shares of common stock owned of record by Mr. More, 2,248 shares of common stock issuable upon settlement of restricted stock units which will vest and settle within 60 days of March 1, 2017, 469,850 shares of common stock held by ORR Partners I GP, LP, a limited partnership controlled by Avery More, 28,752 shares held by Avery More's wife, Jerralyn Smith More, as to which Avery More disclaims any ownership interest and 25,000 shares held by MentorMore Foundation, a private charitable foundation of which Avery More serves as President; Avery More disclaims any ownership interest in such shares.
|
| (16) |
Consists of 10,760 shares of common stock owned of record by Ms. Payne and 2,248 shares of common stock issuable upon settlement of
restricted stock units
which will vest and settle within 60 days of March 1, 2017.
|
| (17) |
Consists of 4,758,977 shares of common stock, 2,022,307 shares of common stock issuable upon exercise of
options
exercisable within 60 days of March 1, 2017, and 13,488 shares of common stock issuable upon settlement of restricted stock units which will vest and settle
within 60 days of March 1, 2017.
|
|
|
|
The Compensation Committee,
Avery More, Chairman
Dan Avida
Marcel Gani
Doron Inbar
|
|
|
•
|
|
motivate our executives to maximize stockholder value;
|
|
|
•
|
|
provide compensation that varies based on performance; and
|
|
|
•
|
|
attract and retain managerial talent, without promoting unreasonable risk taking.
|
|
|
•
|
|
robust selling restrictions;
|
|
|
•
|
|
restrictions on hedging and pledging the Company’s common stock;
|
|
|
•
|
|
use of objective, performance criteria in our short- and long-term incentive plans;
|
|
|
•
|
|
advice from independent compensation consultants retained by the compensation committee;
|
|
|
•
|
|
no specific retirement benefit plans designed solely for senior executives or related entitlements such as executive benefits and perquisites, tax gross-ups, etc.
|
| · |
Guy Sella, our Chief Executive Officer and Chairman of the Board;
|
| · |
Ronen Faier, our Chief Financial Officer;
|
| · |
Zvi Lando, our Vice President, Global Sales;
|
| · |
Yoav Galin, our VP Research and Development; and
|
| · |
Lior Handelsman, our VP Marketing & Product Strategy.
|
|
|
•
|
|
Pay for Performance:
Motivate, recognize and reward superior performance and individual contributions.
|
|
|
•
|
|
Alignment of Interests:
We seek to align the interests of our senior executives with those of our stockholders.
|
|
|
•
|
|
Attraction, Motivation, and Retention of Talent:
Our senior executive compensation programs are designed to help us attract, motivate and retain key management talent who drive profitability and the creation of stockholder value
|
|
Compensation Element
|
Form
|
Objective
|
Rationale / Key Characteristics
|
|
|
Base Salary
|
Cash
|
Attraction
Retention
Performance
|
•
•
•
|
Fixed compensation
Intended to be commensurate with each senior executive’s position and level of responsibility
Evaluated annually or as necessary in response to organizational/business changes, individual performance, market data, etc., but are not automatically increased
|
|
Annual Cash Incentive Compensation
|
Cash
|
Performance
Alignment of Interests
Motivation
|
•
•
•
•
|
Tied to Company and, for all NEOs other than the CEO, individual performance
Designed to reward achievement of annual performance goals that we consider important contributors to stockholder value
Performance goals and targets are established by the compensation committee at the beginning of each calendar year
The compensation committee approves annual cash incentive award payouts based on the level of achievement of these pre-established goals
|
|
Long-Term Incentives
|
Options
|
Performance
Alignment of Interests
|
•
•
|
Since options have no value unless the value of our common stock increases, it aligns the interests with our stockholders.
The multiyear vesting encourages retention since recipients need to remain employed in order for vesting to occur.
|
|
Restricted Stock Units
|
Performance
Alignment of Interest
Retention
Motivation
|
• |
Variable compensation designed to reward contributions to our long-term strategic, financial and operational success, motivate future performance, align the interests of senior executives with those of stockholders and retain key senior executives through the term of the awards
|
|
|
Other Compensation and Benefits
|
N/A
|
Attraction
Retention
|
•
•
|
NEOs receive benefits that are generally available to all salaried employees in Israel, where the NEOs are located. This includes contributions to an education fund and to a fund known as Manager’s Insurance, which provides a combination of retirement plan, insurance and severance pay benefits to Israeli employees.
NEOs receive benefits that we generally make available to all salaried employees, including participation in the Employee Stock Purchase Plan.
|
|
Change in Control Arrangements
|
Equity
|
Attraction
Retention
|
•
•
•
•
|
Our CEO has a clause in his employment agreement that entitles him to immediate vesting of equity in the event of a qualifying termination within one year following a change in control (“double-trigger” equity vesting)
Keep management’s highest priority on stockholder interests in the face of events that may result in a change-in-control and not on potential individual implications of any such events
Reasonable change-in-control protections for our senior executives are necessary in order for us to attract and retain qualified employees
We periodically review the necessity and design of our senior executive severance and change-in-control arrangements
|
|
August 2015 Base Salary Decisions
|
||||||||||||
|
Name and Principal Position
|
Annual base
salary prior to
increase ($)
|
Annual base
salary after
increase ($)
|
Percentage
increase
|
|||||||||
|
Guy Sella - Chief Executive Officer and Chairman of the Board
|
323,077
|
510,000
|
58
|
%
|
||||||||
|
Ronen Faier - Chief Financial Officer
|
184,615
|
300,000
|
63
|
%
|
||||||||
|
Zvi Lando - Vice President, Global Sales
|
215,385
|
300,000
|
39
|
%
|
||||||||
|
Yoav Galin - VP Research and Development
|
184,615
|
275,000
|
49
|
%
|
||||||||
|
August 2016 Base Salary Decisions
|
||||||||||||
|
Name and Principal Position
|
Annual base
salary prior to
increase ($)
|
Annual base
salary after
increase ($)
|
Percentage
increase
|
|||||||||
|
Guy Sella - Chief Executive Officer and Chairman of the Board
|
510,000
|
550,000
|
8
|
%
|
||||||||
|
Ronen Faier - Chief Financial Officer
|
300,000
|
315,000
|
5
|
%
|
||||||||
|
Zvi Lando - Vice President, Global Sales
|
300,000
|
315,000
|
5
|
%
|
||||||||
|
Yoav Galin - VP Research and Development
|
275,000
|
290,000
|
5
|
%
|
||||||||
|
Lior Handelsman - VP Marketing & Product Strategy
|
240,000
|
265,000
|
10
|
%
|
||||||||
| · |
the balance between annual and long-term compensation, including the fact that a significant portion of compensation is delivered in the form of equity incentives that vest over several years;
|
| · |
the use of multiple financial metrics for performance-based annual and long-term incentive awards and the use of individual goals under our annual cash incentive program;
|
| · |
the compensation committee’s ability to modify annual cash incentives to reflect the quality of earnings, individual performance, and other factors that it believes should influence compensation; and
|
| · |
our management stock selling restrictions encourage a longer-term perspective and align the interests of senior executives and the Board, as applicable, with other stockholders.
|
|
Name and Principal
Position
|
Year
|
Salary
($)(1) |
Bonus
($)(1) |
Option
Awards
($)(4)
|
Stock
Awards
($)(4)
|
Non-Equity
Incentive Plan Compensation
($)(1)(5)
|
All Other
Compensation ($)(1) |
Total
($) |
||||||||||||||||||||||
|
Guy Sella
-
|
2016SP
|
274,135
|
499,793
|
505,551
|
503,073
|
42,801(6
|
)
|
1,825,353
|
||||||||||||||||||||||
| Chief Executive Officer and |
2016
|
483,192
|
—
|
641,051
|
903,240
|
714,528
|
72,435(7
|
)
|
2,814,446
|
|||||||||||||||||||||
| Chairman of the Board |
2015
|
298,114
|
243,808(3
|
)
|
4,650,956
|
174,348
|
46,749(8
|
)
|
5,413,975
|
|||||||||||||||||||||
|
2014
|
273,746
|
218,150(2
|
)
|
—
|
—
|
43,732(9
|
)
|
535,628
|
||||||||||||||||||||||
|
Ronen Faier -
|
2016SP
|
158,355
|
162,157
|
164,028
|
203,923
|
24,931(10
|
)
|
713,395
|
||||||||||||||||||||||
| Chief Financial |
2016
|
283,315
|
—
|
256,420
|
361,296
|
260,841
|
42,666(11
|
)
|
1,204,538
|
|||||||||||||||||||||
| Officer |
2015
|
180,319
|
92,879(3
|
)
|
154,399
|
59,574
|
28,720(12
|
)
|
515,891
|
|||||||||||||||||||||
|
2014
|
188,201
|
63,991(2
|
)
|
—
|
—
|
29,850(13
|
)
|
282,042
|
||||||||||||||||||||||
|
Zvi Lando -
|
2016SP
|
158,355
|
162,157
|
164,028
|
195,864
|
25,932(14
|
)
|
706,337
|
||||||||||||||||||||||
| Vice President, |
2016
|
288,503
|
—
|
256,420
|
361,296
|
247,065
|
46,329(15
|
)
|
1,199,614
|
|||||||||||||||||||||
| Global Sales |
2015
|
190,260
|
—
|
154,399
|
71,815
|
31,688(16
|
)
|
448,162
|
||||||||||||||||||||||
|
2014
|
178,223
|
79,544(2
|
)
|
—
|
—
|
26,588(17
|
)
|
284,355
|
||||||||||||||||||||||
|
Yoav Galin -
VP Research
|
2016SP
|
145,584
|
162,157
|
164,028
|
178,415
|
24,220(18
|
)
|
674,405
|
||||||||||||||||||||||
| and Development |
2016
|
262,299
|
—
|
256,420
|
361,296
|
235,933
|
42,256(19
|
)
|
1,158,204
|
|||||||||||||||||||||
|
Lior Handelsman -
|
||||||||||||||||||||||||||||||
|
VP Marketing &
Product Strategy
|
2016SP
|
131,106
|
—
|
94,464
|
95,540
|
164,533
|
20,979(20
|
) |
506,622
|
|||||||||||||||||||||
| (1) |
We paid the amounts reported for each named executive officer in New Israeli Shekels. We have translated amounts paid in New Israeli Shekels into U.S. dollars at the foreign exchange rate published by the Bank of Israel as of the date of payment.
|
| (2) |
Represents discretionary bonuses paid to Mr. Sella, Mr. Faier and Mr. Lando in respect of the Company’s performance in calendar 2014.
|
| (3) |
Represents one time bonuses to Mr. Sella and Mr. Faier in connection with the completion of our initial public offering.
|
| (4) |
The amounts in this column represent the aggregate grant date fair value of the
equity-based
awards granted to our NEOs, computed in accordance with FASB ASC Topic 718. We provide information regarding the assumptions used to calculate the value of the
equity-based
awards in Note 2v to the audited consolidated financial statements included in our Annual Report on Form 10-KT filed on February 12, 2017. There can be no assurance that these awards will vest or will be exercised (in which case no value will be realized by the individual), or that the value upon exercise will approximate the aggregate grant date fair value. The values reported in the table for performance-based restricted stock units were calculated assuming that all applicable performance goals would be achieved.
|
| (5) |
Represents the cash bonuses earned pursuant to our Management By Objectives (MBO) program. Cash bonuses are paid for a full calendar year, therefore the Non-Equity Incentive Plan Compensation for the Stub Period reflects the full cash bonus earned during calendar 2016.
|
| (6) |
Includes a $22,835 contribution by the Company to Mr. Sella’s severance fund and $19,965 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (7) |
Includes a $40,250 contribution by the Company to Mr. Sella’s severance fund and $32,185 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (8) |
Includes a $24,833 contribution by the Company to Mr. Sella’s severance fund and $21,916 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (9) |
Includes a $22,812 contribution by the Company to Mr. Sella’s severance fund and $20,920 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (10) |
Includes a $12,674 contribution by the Company to Mr. Faier’s severance fund and $12,257 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (11) |
Includes a $22,772 contribution by the Company to Mr. Faier’s severance fund and $19,894 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance
|
| (12) |
Includes a $15,021 contribution by the Company to Mr. Faier’s severance fund and $13,699 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (13) |
Includes a $15,683 contribution by the Company to Mr. Faier’s severance fund and $14,167 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (14) |
Includes a $13,191 contribution by the Company to Mr. Lando’s severance fund and $12,741 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (15) |
Includes a $24,032 contribution by the Company to Mr. Lando’s severance fund and $22,297 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (16) |
Includes a $15,849 contribution by the Company to Mr. Lando’s severance fund and $15,839 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (17) |
Includes a $14,852 contribution by the Company to Mr. Lando’s severance fund and $11,736 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (18) |
Includes a $12,127 contribution by the Company to Mr. Galin’s severance fund and $12,093 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (19) |
Includes a $21,850 contribution by the Company to Mr. Galin’s severance fund and $20,406 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (20) |
Includes a $10,371 contribution by the Company to Mr. Handelsman’s severance fund and $10,607 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
|
Name
|
Equity Award Grant Date
|
Estimated Future Payouts
under Non-Equity Incentive
Plan Awards
|
Estimated Future Payouts
under Non-Equity Incentive
Plan Awards
|
All Other Stock Awards: Number of Shares of Stock or Units
|
All Other Option Awards: Number of Securities Underlying Options
|
Exercise or Base Price of Option Awards ($/Share)
|
Grant Date Fair Value of Stock & Option Awards ($)(1)
|
||||
|
Threshold
($)(5)
|
Target
($)
|
Maximum
($)
|
Threshold
($)
|
Target
($)
|
Maximum
($)
|
||||||
|
Guy Sella
|
550,000
|
550,000
|
|||||||||
|
8/23/2016
|
54,813
|
$17.14
|
499,793
|
||||||||
|
8/23/2016
|
29,172
|
505,551
|
|||||||||
|
8/19/2015
|
48,000
|
$25.09
|
641,051
|
||||||||
|
8/19/2015
|
30,000
|
752,700
|
|||||||||
|
8/19/2015
|
0
|
6,000(2)
|
6,000
|
150,540
|
|||||||
|
Ronen Faier
|
210,000
|
210,000
|
|||||||||
|
8/23/2016
|
17,784
|
$17.14
|
162,157
|
||||||||
|
8/23/2016
|
9,465
|
164,028
|
|||||||||
|
8/19/2015
|
19,200
|
$25.09
|
256,420
|
||||||||
|
8/19/2015
|
12,000
|
301,080
|
|||||||||
|
8/19/2015
|
0
|
2,400 (3)
|
2,400
|
60,216
|
|||||||
|
Zvi Lando
|
210,000
|
210,000
|
|||||||||
|
8/23/2016
|
17,784
|
$17.14
|
162,157
|
||||||||
|
8/23/2016
|
9,465
|
164,028
|
|||||||||
|
8/19/2015
|
19,200
|
$25.09
|
256,420
|
||||||||
|
8/19/2015
|
12,000
|
301,080
|
|||||||||
|
8/19/2015
|
0
|
2,400 (3)
|
2,400
|
60,216
|
|||||||
|
Yoav Galin
|
193,333
|
193,333
|
|||||||||
|
8/23/2016
|
17,784
|
$17.14
|
162,157
|
||||||||
|
8/23/2016
|
9,465
|
164,028
|
|||||||||
|
8/19/2015
|
19,200
|
$25.09
|
256,420
|
||||||||
|
8/19/2015
|
12,000
|
301,080
|
|||||||||
|
8/19/2015
|
0
|
2,400 (3)
|
2,400
|
60,216
|
|||||||
|
Lior Handelsman
|
176,667
|
176,667
|
|||||||||
|
8/23/2016
|
10,360
|
$17.14
|
94,464
|
||||||||
|
8/23/2016
|
5,513
|
95,540
|
|||||||||
|
8/19/2015
|
11,200
|
$25.09
|
149,579
|
||||||||
|
8/19/2015
|
7,000
|
175,630
|
|||||||||
|
8/19/2015
|
0
|
1,400 (4)
|
1,400
|
35,126
|
|||||||
| (1) |
The amounts in this column represent the aggregate grant date fair value of the equity based awards granted to our NEOs, computed in accordance with FASB ASC Topic 718. We provide information regarding the assumptions used to calculate the value of these equity based awards in Note 2v to the audited consolidated financial statements included in our Annual Report on Form 10-KT filed on February 21, 2017. There can be no assurance that these awards will vest or will be exercised (in which case no value will be realized by the individual), or that the value upon exercise will approximate the aggregate grant date fair value.
|
| (2) |
| (3) |
Represents the grant of 2,400 performance-based restricted stock units, of which 100% were achieved based on the performance goal criterion.
|
| (4) |
Represents the grant of 1,400 performance-based restricted stock units, of which 100% were achieved based on the performance goal criterion.
|
| (5) |
The Non-Equity Incentive Plan does not include any thresholds or a maximum cap for the Non-Equity Awards
.
|
|
Option Awards
|
Stock Awards
|
||||||||||||||||||||||
|
Name
|
Number of
Securities Underlying Unexercised Options Exercisable |
Number of
Securities Underlying Unexercised Options Unexercisable |
Option
Exercise Price ($) |
Option
Expiration Date |
Number of
Shares or Units of Stock that have not Vested |
Market
Value of Shares or Units of Stock that have not Vested ($) |
|||||||||||||||||
|
Guy Sella
|
73,333
|
—
|
$
|
1.50
|
July 1, 2019
|
—
|
—
|
||||||||||||||||
|
76,667
|
—
|
$
|
2.46
|
January 26, 2022
|
—
|
—
|
|||||||||||||||||
|
36,111
|
30,555
|
(1)
|
$
|
5.01
|
October 29, 2024
|
—
|
—
|
||||||||||||||||
|
388,627
|
388,626
|
(2)
|
$
|
5.01
|
December 22, 2024
|
—
|
—
|
||||||||||||||||
|
15,000
|
33,000
|
(3)
|
$
|
25.09
|
August 19, 2025
|
—
|
—
|
||||||||||||||||
|
3,426
|
51,387
|
(4)
|
$
|
17.14
|
August 23, 2026
|
—
|
—
|
||||||||||||||||
|
—
|
—
|
—
|
—
|
24,750
|
(5)
|
$
|
306,900
|
||||||||||||||||
|
—
|
—
|
—
|
—
|
27,349
|
(6)
|
$
|
339,128
|
||||||||||||||||
|
Ronen Faier
|
100,000
|
—
|
$
|
2.01
|
January 25, 2021
|
—
|
—
|
||||||||||||||||
|
91,666
|
—
|
$
|
2.46
|
January 26, 2022
|
—
|
—
|
|||||||||||||||||
|
36,111
|
30,556
|
(1)
|
$
|
5.01
|
October 29, 2024
|
—
|
—
|
||||||||||||||||
|
6,000
|
13,200
|
(3)
|
$
|
25.09
|
August 19, 2025
|
—
|
—
|
||||||||||||||||
|
1,112
|
16,672
|
(4)
|
$
|
17.14
|
August 23, 2026
|
||||||||||||||||||
|
—
|
—
|
—
|
—
|
9,900
|
(5)
|
$
|
122,760
|
||||||||||||||||
|
—
|
—
|
—
|
—
|
8,874
|
(6)
|
$
|
110,038
|
||||||||||||||||
|
Zvi Lando
|
98,333
|
—
|
$
|
1.50
|
May 28, 2019
|
—
|
—
|
||||||||||||||||
|
63,333
|
—
|
$
|
2.01
|
January 25, 2021
|
—
|
—
|
|||||||||||||||||
|
68,333
|
—
|
$
|
2.46
|
January 26, 2022
|
—
|
—
|
|||||||||||||||||
|
36,111
|
30,556
|
(1)
|
$
|
5.01
|
October 29, 2024
|
—
|
—
|
||||||||||||||||
|
6,000
|
13,200
|
(3)
|
$
|
25.09
|
August 19, 2025
|
—
|
—
|
||||||||||||||||
|
1,112
|
16,672
|
(4)
|
$
|
17.14
|
August 23, 2026
|
||||||||||||||||||
|
—
|
—
|
—
|
—
|
9,900
|
(5)
|
$
|
122,760
|
||||||||||||||||
|
—
|
—
|
—
|
—
|
8,874
|
(6)
|
$
|
110,038
|
||||||||||||||||
|
Yoav Galin
|
75,000
|
—
|
$
|
2.46
|
January 26, 2022
|
—
|
—
|
||||||||||||||||
|
36,111
|
30,556
|
(1)
|
$
|
5.01
|
October 29, 2024
|
—
|
—
|
||||||||||||||||
|
6,000
|
13,200
|
(3)
|
$
|
25.09
|
August 19, 2025
|
—
|
—
|
||||||||||||||||
|
1,112
|
16,672
|
(4)
|
$
|
17.14
|
August 23, 2026
|
||||||||||||||||||
|
—
|
—
|
—
|
—
|
9,900
|
(5)
|
$
|
122,760
|
||||||||||||||||
|
—
|
—
|
—
|
—
|
8,874
|
(6)
|
$
|
110,038
|
||||||||||||||||
|
Lior Handelsman
|
73,333
|
—
|
$
|
1.50
|
July 1, 2019
|
—
|
—
|
||||||||||||||||
|
76,667
|
—
|
$
|
2.46
|
January 26, 2022
|
—
|
—
|
|||||||||||||||||
|
36,111
|
30,555
|
(1)
|
$
|
5.01
|
October 29, 2024
|
—
|
—
|
||||||||||||||||
|
3,500
|
7,700
|
(3)
|
$
|
25.09
|
August 19, 2025
|
—
|
—
|
||||||||||||||||
|
647
|
9,713
|
(4)
|
$
|
17.14
|
August 23, 2026
|
||||||||||||||||||
|
—
|
—
|
—
|
—
|
5,776
|
(5)
|
$
|
71,622
|
||||||||||||||||
|
—
|
—
|
—
|
—
|
5,169
|
(6)
|
$
|
64,096
|
| (1) |
The shares subject to the stock option vest over a four‑year period commencing October 31, 2014, with 1/48 of the shares vesting monthly thereafter.
|
| (2) |
The shares subject to the stock option vest over a four‑year period commencing December 31, 2014, with 1/48 of the shares vesting monthly thereafter.
|
| (3) |
The shares subject to the stock option vest over a four‑year period commencing August 31, 2015, with 1/16 of the shares vesting quarterly thereafter.
|
| (4) |
The shares subject to the stock option vest over a four‑year period commencing August 31, 2016, with 1/16 of the shares vesting quarterly thereafter.
|
| (5) |
The shares subject to the RSU vest over a four-year period commencing on August 31, 2015, with 1/16 of the shares vesting quarterly thereafter.
|
| (6) |
The shares subject to the RSU vest over a four-year period commencing on August 31, 2016, with 1/16 of the shares vesting quarterly thereafter.
|
|
Option Awards
|
Stock Awards
|
|||||||||||||||
|
Name
|
Number of Shares
Acquired on
Exercise
|
Value Realized
upon Exercise
($)(1)
|
Number of Shares
Acquired on
Vesting
|
Value Realized on
Vesting ($)(2) |
||||||||||||
|
Guy Sella
|
-
|
-
|
6,323
|
$
|
92,059
|
|||||||||||
|
Ronen Faier
|
-
|
-
|
2,391
|
$
|
34,999
|
|||||||||||
|
Zvi Lando
|
-
|
-
|
2,391
|
$
|
34,999
|
|||||||||||
|
Yoav Galin
|
-
|
-
|
2,391
|
$
|
34,999
|
|||||||||||
|
Lior Handelsman
|
-
|
-
|
1,394
|
$
|
20,410
|
|||||||||||
|
Name: Guy Sella
|
Termination
upon Death
of Employee
|
Termination
for Cause
|
Voluntary
Termination
by Employee
After
Provision of
Requisite
Notice
|
Termination
by Company
After
Provision of
Requisite
Notice
|
Termination
w/o Cause or
for Good Reason
|
Termination
w/o Cause or
for Good
Reason within
12 months of
Change in
Control
|
||||||||||||||||||
|
Base Salary
|
-
|
-
|
139,467
|
139,467
|
139,467
|
139,467
|
||||||||||||||||||
|
Israeli Social Benefits
|
-
|
-
|
21,948
|
21,948
|
21,948
|
21,948
|
||||||||||||||||||
|
Unvested Options/RSUs (1)
|
-
|
-
|
440,293
|
440,293
|
440,293
|
3,743,783
|
||||||||||||||||||
|
Accrued Vacation Pay
|
355,506
|
355,506
|
355,506
|
355,506
|
355,506
|
355,506
|
||||||||||||||||||
|
TOTAL
|
355,506
|
355,506
|
957,214
|
957,214
|
957,214
|
4,260,704
|
||||||||||||||||||
| (1) |
The value realized is based on the difference between the exercise price of the stock options and the closing price of our common stock on the last trading day of the Stub Period and, in the case of RSUs, the number of RSUs that would have vested multiplied by the closing price of our common stock on the last trading day of the Stub Period.
|
|
Name: Ronen Faier
|
Termination
upon Death
of Employee
|
Termination
for Cause
|
Voluntary
Termination
by Employee
After
Provision of
Requisite
Notice
|
Termination
by Company
After
Provision of
Requisite
Notice
|
Termination
w/o Cause or
for Good Reason
|
Termination
w/o Cause or
for Good
Reason within
12 months of
Change in
Control
|
||||||||||||||||||
|
Base Salary
|
-
|
-
|
53,251
|
53,251
|
53,251
|
53,251
|
||||||||||||||||||
|
Israeli Social Benefits
|
-
|
-
|
8,069
|
8,069
|
8,069
|
8,069
|
||||||||||||||||||
|
Unvested Options/RSUs (1)
|
-
|
-
|
39,023
|
39,023
|
39,023
|
39,023
|
||||||||||||||||||
|
Accrued Vacation Pay
|
76,991
|
76,991
|
76,991
|
76,991
|
76,991
|
76,991
|
||||||||||||||||||
|
TOTAL
|
76,991
|
76,991
|
177,334
|
177,334
|
177,334
|
177,334
|
||||||||||||||||||
| (1) |
The value realized is based on the difference between the exercise price of the stock options and the closing price of our common stock on the last trading day of the Stub Period and, in the case of RSUs, the number of RSUs that would have vested multiplied by the closing price of our common stock on the last trading day of the Stub Period.
|
|
Name: Zvi Lando
|
Termination
upon Death
of Employee
|
Termination
for Cause
|
Voluntary
Termination
by Employee
After
Provision of
Requisite
Notice
|
Termination
by Company
After
Provision of
Requisite
Notice
|
Termination
w/o Cause or
for Good Reason
|
Termination
w/o Cause within
12 months of
Change in
Control(2)
|
||||||||||||||||||
|
Base Salary
|
-
|
-
|
53,251
|
53,251
|
53,251
|
53,251
|
||||||||||||||||||
|
Israeli Social Benefits
|
-
|
-
|
8,367
|
8,367
|
8,367
|
8,367
|
||||||||||||||||||
|
Unvested Options/RSUs (1)
|
-
|
-
|
39,023
|
39,023
|
39,023
|
39,023
|
||||||||||||||||||
|
Accrued Vacation Pay
|
118,276
|
118,276
|
118,276
|
118,276
|
118,276
|
118,276
|
||||||||||||||||||
|
TOTAL
|
118,276
|
118,276
|
218,917
|
218,917
|
218,917
|
218,917
|
||||||||||||||||||
| (1) |
The value realized is based on the difference between the exercise price of the stock options and the closing price of our common stock on the last trading day of the Stub Period and, in the case of RSUs, the number of RSUs that would have vested multiplied by the closing price of our common stock on the last trading day of the Stub Period.
|
|
Name: Yoav Galin
|
Termination
upon Death
of Employee
|
Termination
for Cause
|
Voluntary
Termination
by Employee
After
Provision of
Requisite
Notice
|
Termination
by Company
After
Provision of
Requisite
Notice
|
Termination
w/o Cause or
for Good Reason
|
Termination
w/o Cause or
for Good
Reason within
12 months of
Change in
Control
|
||||||||||||||||||
|
Base Salary
|
-
|
-
|
73,537
|
73,537
|
73,537
|
73,537
|
||||||||||||||||||
|
Israeli Social Benefits
|
-
|
-
|
11,693
|
11,693
|
11,693
|
11,693
|
||||||||||||||||||
|
Unvested Options/RSUs (1)
|
-
|
-
|
49,287
|
49,287
|
49,287
|
49,287
|
||||||||||||||||||
|
Accrued Vacation Pay
|
272,661
|
272,661
|
272,661
|
272,661
|
272,661
|
272,661
|
||||||||||||||||||
|
TOTAL
|
272,661
|
272,661
|
407,178
|
407,178
|
407,178
|
407,178
|
||||||||||||||||||
| (1) |
The value realized is based on the difference between the exercise price of the stock options and the closing price of our common stock on the last trading day of the Stub Period and, in the case of RSUs, the number of RSUs that would have vested multiplied by the closing price of our common stock on the last trading day of the Stub Period).
|
|
Name: Lior Handelsman
|
Termination
upon Death
of Employee
|
Termination
for Cause
|
Voluntary
Termination
by Employee
After
Provision of
Requisite
Notice
|
Termination
by Company
After
Provision of
Requisite
Notice
|
Termination
w/o Cause or
for Good Reason
|
Termination
w/o Cause or
for Good
Reason within
12 months of
Change in
Control
|
||||||||||||||||||
|
Base Salary
|
-
|
-
|
67,198
|
67,198
|
67,198
|
67,198
|
||||||||||||||||||
|
Israeli Social Benefits
|
-
|
-
|
10,273
|
10,273
|
10,273
|
10,273
|
||||||||||||||||||
|
Unvested Options/RSUs (1)
|
-
|
-
|
41,574
|
41,574
|
41,574
|
41,574
|
||||||||||||||||||
|
Accrued Vacation Pay
|
129,828
|
129,828
|
129,828
|
129,828
|
129,828
|
129,828
|
||||||||||||||||||
|
TOTAL
|
129,828
|
129,828
|
248,873
|
248,873
|
248,873
|
248,873
|
||||||||||||||||||
| (1) |
The value realized is based on the difference between the exercise price of the stock options or the base price of the stock appreciation rights and the closing price of our common stock on the last trading day of the Stub Period and, in the case of RSUs, the number of RSUs that would have vested multiplied by the closing price of our common stock on the last trading day of the Stub Period.
|
|
Position
|
Retainer ($)
|
|||
|
Board Member
|
40,000
|
|||
|
Audit Committee Chair
|
20,000
|
|||
|
Compensation Committee Chair
|
15,000
|
|||
|
Nominating and Corporate Governance Committee Chair
|
10,000
|
|||
|
Audit Committee Member
|
10,000
|
|||
|
Compensation Committee Member
|
7,500
|
|||
|
Nominating and Corporate Governance Committee Member
|
5,000
|
|||
|
Name
|
Year
|
Fees
Earned or Paid
in Cash
($)(1)
|
Stock
Awards
($) (2)
|
Option
Awards
($)
|
Non-Equity
Incentive Plan
Compensation
($)
|
Nonqualified
Deferred
Compensation
Earnings ($)
|
All Other
Compensation
($)
|
Total
($)
|
||||||||||||||||||||||
|
Dan Avida (2)
|
2016SP
|
26,250
|
73,332
|
—
|
—
|
—
|
—
|
99,582
|
||||||||||||||||||||||
|
2016
|
40,000
|
-
|
—
|
—
|
—
|
—
|
40,000
|
|||||||||||||||||||||||
|
Yoni Cheifetz
|
2016SP
|
-
|
73,332
|
—
|
—
|
—
|
—
|
73,332
|
||||||||||||||||||||||
|
2016
|
-
|
-
|
—
|
—
|
—
|
—
|
—
|
|||||||||||||||||||||||
|
Marcel Gani
|
2016SP
|
33,750
|
73,332
|
—
|
—
|
—
|
—
|
107,082
|
||||||||||||||||||||||
|
2016
|
55,000
|
-
|
—
|
—
|
—
|
—
|
55,000
|
|||||||||||||||||||||||
|
Doron Inbar
|
2016SP
|
28,750
|
73,332
|
—
|
—
|
—
|
—
|
102,082
|
||||||||||||||||||||||
|
2016
|
40,000
|
-
|
—
|
—
|
—
|
—
|
40,000
|
|||||||||||||||||||||||
|
Avery More
|
2016SP
|
32,500
|
73,332
|
—
|
—
|
—
|
—
|
105,832
|
||||||||||||||||||||||
|
2016
|
50,000
|
-
|
—
|
—
|
—
|
—
|
50,000
|
|||||||||||||||||||||||
|
Tal Payne
|
2016SP
|
25,000
|
73,332
|
—
|
—
|
—
|
—
|
98,332
|
||||||||||||||||||||||
|
2016
|
35,000
|
-
|
—
|
—
|
—
|
—
|
35,000
|
|||||||||||||||||||||||
| (1) |
| (2) |
Represents the grant date fair value of 4,016 restricted stock units granted to each director on August 16, 2016, calculated in accordance with U.S. GAAP. All units became fully vested on February 23, 2017. The grant date fair value is based on $18.26 per share, the closing price of our share on the grant date. As of December 31, 2016, each director held 4,016 unvested restricted stock units.
|
*** Exercise Your Right to Vote ***
Important Notice Regarding the Availability of Proxy Materials for the
Shareholder Meeting to Be Held on May 10, 2017.
| Meeting Information | ||||
|
SOLAREDGE TECHNOLOGIES, INC.
|
Meeting Type: For holders as of: |
Annual Meeting March 13, 2017 |
||
| Date: May 10, 2017 Time: 10:00 AM PDT | ||||
| Location: |
47505 Seabridge Drive
|
|||
|
|
You are receiving this communication because you hold shares in the company named above.
This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).
We encourage you to access and review all of the important information contained in the proxy materials before voting.
|
|||
| See the reverse side of this notice to obtain proxy materials and voting instructions. | ||||
E25039-P87192
| Before You Vote | ||||
How to Access the Proxy Materials
| Proxy Materials Available to VIEW or RECEIVE: | ||||||||
| 2017 NOTICE AND PROXY STATEMENT ANNUAL REPORT ON FORM 10-K | ||||||||
|
How to View Online:
Have the information that is printed in the box marked by the arrow
|
||||||||
|
How to Request and Receive a PAPER or E-MAIL Copy: If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
|
||||||||
| 1) | BY INTERNET : | www.proxyvote.com | ||||||
| 2) | BY TELEPHONE : | 1-800-579-1639 | ||||||
| 3) | BY E-MAIL* : | sendmaterial@proxyvote.com | ||||||
* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow
(located on the following page) in the subject line.
|
||||||||
|
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before April 26, 2017 to facilitate timely delivery.
|
||||||||
| How To Vote | ||||
Please Choose One of the Following Voting Methods
|
Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.
|
||
|
V
ote By Internet:
To vote now by Internet, go to
www.proxyvote.com.
Have the information that is printed in the box marked by the arrow
|
||
|
Vot e By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card. |
||
E25040-P87192
| Voting Items | ||||
|
Company Proposals
The Board of Directors recommends a vote “FOR”
the election of each of the nominees listed below: |
||||
| 1. |
Election of Directors |
|||
| Nominees: | ||||
| 1a. | Tal Payne | |||
| 1b. | Marcel Gani |
| The Board of Directors recommends a vote “FOR” Proposal 2. | |
| 2. | Ratification of appointment of Kost Forer Gabbay & Kasierer a member of Ernst & Young Global as independent registered public accounting firm for the year ending December 31, 2017. |
| The Board of Directors recommends a vote of “1 YEAR” with respect to Proposal 3. | |
| 3. | To approve, on an advisory and non-binding basis, the frequency with which stockholders are provided an advisory vote to approve executive compensation. |
| NOTE: Such other business as may properly come before the meeting or any adjournment or postponement thereof. | |
E25041-P87192
|
E25038-P87192
|
|
SOLAREDGE TECHNOLOGIES, INC.
|
|||||||
|
Hamada 1
|
|||||||
|
Herzliya Pituach, Israel
|
|||||||
| THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS | |||||||
|
The undersigned hereby appoints Ronen Faier and Rachel Prishkolnik, and each of them, with full power of substitution and power to act alone, as proxies to vote all the shares of Common Stock which the undersigned would be entitled to vote if personally present and acting at the Annual Meeting of Shareholders of SolarEdge Technologies, Inc., to be held at the Company’s US offices located at 47505 Seabridge Drive, Fremont, California 94538, on May 10, 2017, and at any adjournments or postponements thereof.
|
|||||||
|
In their discretion, the proxies are authorized to vote upon such other business as may properly come before the Annual Meeting of Shareholders.
|
|||||||
|
This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors’ recommendations.
|
|||||||
| Address Changes/Comments: | |||||||
|
(If you noted any Address Changes/Comments above, please mark corresponding box on the reverse side.)
|
|||||||
|
(Continued and to be signed on reverse side.)
|
|||||||
V.1.1
|
SOLAREDGE TECHNOLOGIES, INC.
HAMADA 1
HERZLIYA PITUACH, ISRAEL
|
VOTE BY INTERNET -
www.proxyvote.com
Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. (PT) on May 9, 2017 the day before meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.
ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS
If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.
VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. (PT) on May 9, 2017 the day before meeting date. Have your proxy card in hand when you call and then follow the instructions.
VOTE BY MAIL
Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
|
|
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
|
||
|
E25037-P87192
|
KEEP THIS PORTION FOR YOUR RECORDS | |
| THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. | DETACH AND RETURN THIS PORTION ONLY | |
|
SOLAREDGE TECHNOLOGIES, INC.
|
|||||||||||||||
|
Company Proposals
|
|
||||||||||||||
|
The Board of Directors recommends a vote “FOR” the election of each of the nominees listed below:
|
|||||||||||||||
| 1. |
Election of Directors
|
||||||||||||||
|
Nominees:
|
For | Against | Abstain | ||||||||||||
|
1a. Tal Payne
|
☐ | ☐ | ☐ | ||||||||||||
|
1b. Marcel Gani
|
☐ | ☐ | ☐ | ||||||||||||
|
The Board of Directors recommends a vote “FOR” Proposal 2.
|
For | Against | Abstain | ||||||||||||
| 2. |
Ratification of appointment of Kost Forer Gabbay & Kasierer a member of Ernst & Young Global as independent registered public accounting firm for the year ending December 31, 2017.
|
☐ | ☐ | ☐ | |||||||||||
|
The Board of Directors recommends a vote of “1 YEAR” with respect to Proposal 3.
|
1 Year | 2 Years | 3 Years | Abstain | |||||||||||
| 3. |
To approve, on an advisory and non-binding basis, the frequency with which stockholders are provided an advisory vote to approve executive compensation.
|
☐ | ☐ | ☐ | ☐ | ||||||||||
|
NOTE:
Such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
|||||||||||||||
|
For address changes and/or comments, please check this box and write them on the back where indicated.
|
☐ | ||||||||||||||
|
Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.
|
|||||||||||||||
|
|
|||||||||||||||
| Signature [PLEASE SIGN WITHIN BOX] | Date | Signature (Joint Owners) | Date | ||||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|